(function(){var loadHandler=window['sl_{07577339-214E-45D2-8349-B551DFC3D55F}'];loadHandler&&loadHandler(31, '<div id="spr0_5382ce9"><div id="spr1_5382ce9" class="kern"><img id="img2_5382ce9" src="data/img5.png" width="960px" height="540px" alt="" style="left:0px;top:0px;"/><div id="spr3_5382ce9" style="left:-3px;top:71px;"><img id="img0_5382ce9" src="data/img6.png" width="968" height="120" alt=""/></div><div id="spr4_5382ce9" style="left:0px;top:-0.625px;"><img id="img1_5382ce9" src="data/img7.png" width="961" height="156.326" alt=""/></div></div><div id="spr2_5382ce9" class="kern"><div id="spr5_5382ce9" style="left:48px;top:21.625px;"><div style="width:0px;"><span id="txt0_5382ce9" class="relpos" style="left:103.728px;top:11.383px;">What are the new findings?</span></div></div><div id="spr6_5382ce9" style="left:48px;top:133.922px;"><div style="width:0px;"><span id="txt1_5382ce9" class="nokern relpos" style="left:7.2px;top:5.098px;">•</span><span id="txt2_5382ce9" class="relpos" style="left:22.997px;top:5.247px;">Low-level mutations in TP53, PIK3CA and/or PTEN were</span></div><div style="width:0px;"><span id="txt3_5382ce9" class="relpos" style="left:34.2px;top:43.647px;">detected in IPMNs with low-grade dysplasia and may</span></div><div style="width:0px;"><span id="txt4_5382ce9" class="relpos" style="left:34.2px;top:82.047px;">represent a subset of IPMNs at risk for malignant</span></div><div style="width:0px;"><span id="txt5_5382ce9" class="relpos" style="left:34.2px;top:120.447px;">transformation.</span></div><div style="width:0px;"><span id="txt6_5382ce9" class="nokern relpos" style="left:7.2px;top:166.378px;">•</span><span id="txt7_5382ce9" class="relpos" style="left:22.997px;top:166.527px;">Mutant allele frequencies for </span><span id="txt8_5382ce9" class="relpos" style="left:22.992px;top:166.527px;">GNAS</span><span id="txt9_5382ce9" class="relpos" style="left:22.987px;top:166.527px;"> mutations &gt;55%</span></div><div style="width:0px;"><span id="txt10_5382ce9" class="relpos" style="left:34.2px;top:204.927px;">correlated with IPMNs with high-grade dysplasia.</span></div><div style="width:0px;"><span id="txt11_5382ce9" class="nokern relpos" style="left:7.2px;top:250.858px;">•</span><span id="txt12_5382ce9" class="relpos" style="left:22.997px;top:251.007px;">The usage of preoperative NGS result in accurately</span></div><div style="width:0px;"><span id="txt13_5382ce9" class="relpos" style="left:34.2px;top:289.407px;">classifying PCs and the detection of IPMNs harbouring</span></div><div style="width:0px;"><span id="txt14_5382ce9" class="relpos" style="left:34.2px;top:327.807px;">advanced neoplasia.</span></div></div><div id="spr7_5382ce9" style="left:786.204px;top:511.855px;"><div style="width:0px;"><span id="txt15_5382ce9" class="relpos" style="left:8.85px;top:4.31px;">Gut 2018;676:2131-2141</span></div></div></div></div>');})();